XML 122 R110.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Details) - Schedule of changes in the fair value of warrant liabilities - CM Life Sciences, Inc. - USD ($)
3 Months Ended 6 Months Ended
Mar. 31, 2021
Dec. 31, 2020
Private Placement    
Fair Value, Net Assets (Liability) Rollforward [Roll Forward]    
Fair value at beginning of period $ 30,032,168 $ 0
Initial measurement on September 4, 2020   10,855,001
Change in valuation inputs or other assumptions 20,479,768 19,177,167
Fair value at end of period 50,511,936 30,032,168
Public    
Fair Value, Net Assets (Liability) Rollforward [Roll Forward]    
Fair value at beginning of period 40,290,250 0
Initial measurement on September 4, 2020   20,956,833
Change in valuation inputs or other assumptions 36,157,914 19,333,417
Fair value at end of period 76,448,164 40,290,250
Total Warrant Liabilities    
Fair Value, Net Assets (Liability) Rollforward [Roll Forward]    
Fair value at beginning of period 70,322,418 0
Initial measurement on September 4, 2020   31,811,834
Change in valuation inputs or other assumptions 56,637,682 38,510,584
Fair value at end of period $ 126,960,100 $ 70,322,418